Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • Nestle India to launch...

    Nestle India to launch nearly three dozen products in 2019, eyes higher exports

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-02-20T09:30:14+05:30  |  Updated On 16 Aug 2021 3:32 PM IST

    Nestle, whose 6 per cent revenues come from exports, is now looking to tap more overseas markets by targeting countries with higher Indian diaspora such as SAARC and South East Asia.


    New Delhi: FMCG major Nestle India has lined up nearly two-three dozen products that it plans to launch in the calendar year 2019 across categories in the country to drive its aggressive growth plans, Chairman and Managing Director Suresh Narayanan said Monday.


    The company, whose 6 per cent revenues come from exports, is now looking to tap more overseas markets by targeting countries with higher Indian diaspora such as SAARC and South East Asia.


    "In 2018, our core brands have performed well...We look forward for greater acceleration as we go forward....We have two-three dozen projects (products) in the pipeline for launch in 2019. These products are across categories," Narayanan told reporters.


    Read Also: Nestle Maggi Controversy: SC revives Rs 640 crore class action suit


    Reiterating the company's focus on the Indian market, he said, "As an organisation, the one clarion call that we are working to is that we are in the business of growth to thrive and not to survive...It is not a survival mode that we look at the opportunity in India or the opportunity for growth..but a thriving mode."


    While the domestic market has been driving its growth, Narayanan said Nestle India would now look at expanding its export basket.


    The company is looking at tapping the overseas market with higher Indian diaspora such as SAARC and South East Asia to expand its exports, he added.


    Commenting on fake news on nutrition, Narayanan said it was affecting choices and lives of people.


    Therefore, Nestle India in partnership with Google, using a chatbot mechanism, will launch a personalised information dissemination website called "Ask Nestle", he added.


    Read Also: Nestle raises stake in food allergy drug developer Aimmune


    "Ask Nestle seeks to be a reliable and anchor platform for nutrition and lifestyle information for customers. India is the only market where this website is being launched," he added.


    When asked if the company will in future also link Ask Nestle with its own e-commerce website for selling its products, he said it is a possibility.


    "...Going forward it could morph into something bigger in terms of linking up with our own e-commerce intentions, if at all it happens. But today it is only for information sharing, dissemination and helping," he said.


    When asked if there has been any impact on sales of Maggi Noodles after Supreme Court revived government's case in the National Consumer Disputes Redressal Commission (NCDRC) against Nestle India seeking damages of Rs 640 crore for alleged unfair trade practices, false labelling and misleading advertisements, Narayanan said "No".


    When asked if the company is looking for manufacturing capacity expansion, he said: "...This is a question that is coming up with active consultation. That exercise is on but I can not share more at this stage".


    Read Also: Merck's consumer health sale at risk as Nestle bows out, says report


    Typically, our approach is to augment (capacity) at our existing factories, but it does not rule out a new manufacturing facility, Narayanan said.


    Nestle India, at present, has eight factories across the country.

    The company also did not rule out evaluating inorganic growth in the country and said it may consider it if any opportunity arises.
    alleged unfair trade practicesAsk Nestledisseminationfalse labellingFMCGIndian diasporaMaggi noodlesmisleading advertisementsNational Consumer Disputes Redressal CommissionNCDRCNestleNestle IndiaNew DelhiNutritionSaarcSupreme CourtSuresh Narayanan
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok